DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more
▼ + stars: | 2024-07-08 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.

Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead

☆ Final Trades: Keurig Dr Pepper, Gilead, BlackRock & JEPQ
▼ + stars: | 2024-06-25 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: Keurig Dr Pepper, Gilead, BlackRock & JEPQThe Investment Committee discuss their top stocks to watch for the second half.

Persons: Dr Pepper Organizations: Investment Locations: Gilead, BlackRock

☆ Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
▼ + stars: | 2024-06-21 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Hertz Global — Shares rose more than 10% after the car rental giant upsized a bond offering to $1 billion . Asana — The stock popped 10.5% after the software firm announced a share buyback plan that would cost $150 million. Nvidia — The chipmaker dropped another 1% following a 3.5% decline in the previous session. Gilead Sciences — Shares of the pharmaceutical company popped around 2%, adding to an 8.5% rally from the previous session. Palo Alto Networks — Shares rose 2.4% after D.A.

Persons: Gilead, LendingTree, Davidson, D.A, Boyd Gaming, Boyd, —, Alex Harring, Yun Li, Lisa Kailai Han, Hakyung Kim, Michelle Fox Organizations: Therapeutics, U.S . Food, Drug Administration, FDA, Hertz, Nvidia, Gilead Sciences, Bloomberg, Palo Alto, D.A, Penn Entertainment, Boyd, Reuters, Boeing Locations: U.S, Gilead, Palo, cybersecurity, Thursday's

☆ Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
▼ + stars: | 2024-06-21 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable public company. Nike — The athletic clothing maker moved 1% higher following an upgrade at Oppenheimer to outperform from market perform. Asana — Shares popped more than 3% after the software firm announced a $150 million share buyback plan. Gilead Sciences — The pharmaceutical stock rose more than 2.6%, building on a rally of 8.5% from the previous session. Delta Air Lines — The stock rose 0.7% following news Thursday that the airliner announced a quarterly dividend of 15 cents a share, a 50% increase from previous levels.

Persons: Oppenheimer, Gilead, LendingTree, Bernstein, Toni Sacconaghi, — CNBC's Brian Evans, Michelle Fox, Jesse Pound, Sarah Min Organizations: Nvidia, Microsoft, Sarepta Therapeutics, U.S . Food, Drug Administration, Nike, Gilead Sciences, Bloomberg, Apple —, Air Lines Locations: U.S, Gilead

☆ New Drug Provides Total Protection From H.I.V. in Trial of Young African Women
▼ + stars: | 2024-06-21 | by ( Stephanie Nolen | ) www.nytimes.com time to read: +1 min

Researchers and activists in the trenches of the long fight against H.I.V. got a rare piece of exciting news this week: Results from a large clinical trial in Africa showed that a twice-yearly injection of a new antiviral drug gave young women total protection from the virus. “I got cold shivers,” said Dr. Linda-Gail Bekker, an investigator in the trial of the drug, lenacaprivir, describing the startling sight of a line of zeros in the data column for new infections. and AIDS in South Africa, said it was “the best news ever.”The randomized controlled trial, called Purpose 1, was conducted in Uganda and South Africa. It tested whether the every-six-months injection of lenacaprivir, made by Gilead Sciences, would provide better protection against H.I.V.

Persons: ”, Linda, Gail Bekker, ” Yvette Raphael Organizations: H.I.V, Gilead Sciences Locations: Africa, South Africa, Uganda

☆ CNBC Daily Open: S&P 500 briefly crosses 5,500, closes lower
▼ + stars: | 2024-06-21 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. S&P 500 slips from record highThe S&P 500 briefly passed the 5,500 mark for the first time before ending the session lower. Open AI challengerAnthropic, a leading AI competitor to OpenAI, unveiled Claude 3.5 Sonnet, its most advanced AI model to date. [PRO] AI real estateCiti analysts pinpoint a "compelling emerging" real estate trend fueled by AI and nearshoring.

Persons: Gilead, Anthropic, Claude, Donald Trump's, Trump, Masato Kanda Organizations: New York Stock Exchange, CNBC, Nasdaq, Nvidia, Dow Jones, Gilead Sciences, Google, Trump Media, New, Nikkei, Bank of, Reuters, United, CSI, Citi Locations: New York City, U.S, New York, Japan, United States, Asia, Pacific

☆ Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
▼ + stars: | 2024-06-20 | by ( Angelica Peebles | In Angelicapeebles | ) www.cnbc.com time to read: +3 min

Gilead 's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. The results bring Gilead one step closer to introducing a new form of pre-exposure prophylaxis, or PrEP, and broadening its HIV business. If those results are positive, the company could bring lenacapavir for PrEP to market as soon as late 2025. RBC Capital Markets analyst Brian Abrahams expects Gilead's shot will significantly increase the number of people interested in preventive HIV medicine. In its statement disclosing the lenacapavir trial results Thursday, Gilead said it plans to share an update on how it plans to address access in such countries where people suffer high incidence rates of HIV.

Persons: Gilead, Jared Baeten, Gilead's Truvada, Bruce Richman, Tim Oliver, they'd, Brian Abrahams, Gilead's, — CNBC's Leanne Miller Organizations: Food and Drug Administration, PrEP, Centers for Disease Control, Prevention, Health, FDA, RBC Capital Locations: U.S, New York

☆ Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
▼ + stars: | 2024-06-20 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Trump Media & Technology Group — After former President Donald Trump's company said on Tuesday that the Securities and Exchange Commission had declared effective Trump Media's registration of additional shares, the stock dropped 13.5%. Super Micro Computer — Shares jumped 5% after Elon Musk said the company will help his AI firm, xAI, build a supercomputer . Winnebago reported $1.13 in adjusted earnings per share on $786 million of revenue for its fiscal third quarter. Commercial Metals — Shares gained 5.6% after the company reported a revenue beat for its third quarter. Analysts surveyed by LSEG had forecasted $1.80 earnings per share and $1.65 billion in revenue.

Persons: lenacapavir, Donald Trump's, Elon Musk, Piper Sandler, Winnebago, FactSet, Heather Balsky, Jabil, LSEG, —, Alex Harring, Hakyung Kim, Sarah Min, Jesse Pound, Lisa Han Organizations: Accenture, Gilead Sciences, Trump Media & Technology, Securities and Exchange Commission, Trump, Darden, Garden, LongHorn, LSEG . Revenue, Winnebago Industries, Bank of America, Jazz Pharmaceuticals, Metals, Revenue, KB

☆ These S&P 500 stocks are cheap and well-liked by analysts heading into June
▼ + stars: | 2024-05-30 | by ( Pia Singh | ) www.cnbc.com time to read: +8 min

The company has a low forward price-to-earnings ratio of roughly 8.6. Ulta Beauty also made the screen as a cheap stock that analysts are bullish on. The stock has a 14.5 forward price-to-earnings ratio and a consensus buy rating from analysts polled by FactSet. Online pickup orders inside an Ulta Beauty store in the Upper East Side neighborhood in New York, US, on Monday, Nov. 27, 2023. The stock has a 14.5 forward price-to-earnings ratio and a consensus buy rating from analysts polled by FactSet.

Persons: Jefferies, Trevor Williams, We're, FactSet, Stifel, Ulta, General Motors, Bing Guan Organizations: Dow Jones, Nasdaq, CNBC, Financial, Global Payments, Jefferies, JPMorgan, Cadillac, Chevrolet, General, FedEx, Halliburton, Gilead Sciences, CVS Health, Bloomberg, Getty, CVS, Epam, Motors, HAL Halliburton, Resorts, JBL, LKQ, Vegas Sands Corp, MGM MGM Resorts International, LSEG Financial, Inc Locations: Gilead, New York

☆ Biden’s Warning Over Rafah Sharpens a Problem for Netanyahu
▼ + stars: | 2024-05-09 | by ( Adam Rasgon | ) www.nytimes.com time to read: +1 min

President Biden’s warning over halting weapons supplies has tightened the bind that Prime Minister Benjamin Netanyahu of Israel faces, as he is increasingly caught between international calls for a cease-fire and right-wing Israeli demands to proceed with a wide-scale invasion of Rafah, in southern Gaza. Mr. Netanyahu, who has insisted over American objections that invading Rafah is necessary, now finds the U.S.-Israel relationship at a moment of crisis that could affect how he conducts the next phase of the war against Hamas. On Thursday, the Israeli leader, alluding to Mr. Biden’s remarks, said in a statement: “If we need to stand alone, we will stand alone. I have said that, if necessary, we will fight with our fingernails. “If we lose the United States with the unbelievable friendship of President Biden, it won’t be forgiven,” he added.

Persons: Biden’s, Benjamin Netanyahu, Israel, Netanyahu, God’s, Biden, ”, Amos Gilead Organizations: Hamas, United, United Nations Locations: Rafah, Gaza, U.S, Israel, United States

☆ U.S. Lags Behind Other Countries in Hepatitis-C Treatment
▼ + stars: | 2024-04-28 | by ( Ted Alcorn | ) www.nytimes.com time to read: 1 min

In the 10 years since the drugmaker Gilead debuted a revolutionary treatment for hepatitis C, a wave of new therapies have been used to cure millions of people around the world of the blood-borne virus. Today, 15 countries, including Egypt, Canada and Australia, are on track to eliminate hepatitis C during this decade, according to the Center for Disease Analysis Foundation, a nonprofit. Each has pursued a dogged national screening and treatment campaign. Spread through the blood including IV drug use, hepatitis C causes liver inflammation, though people may not display symptoms for years. Only a fraction of Americans with the virus are aware of the infection, even as many develop the fatal disease.

Organizations: Center, Disease Analysis Locations: Egypt, Canada, Australia, United States

☆ Stocks making the biggest moves after hours: Alphabet, Microsoft, Snap, Intel and more
▼ + stars: | 2024-04-25 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Microsoft – The tech giant saw shares climb 4.5% in extended trading after the software maker posted fiscal third-quarter results that surpassed Wall Street's expectations. Snap – Shares soared more than 27% in afterhours trading after the social media firm reported first-quarter results that beat analysts' estimates. Intel reported earnings that beat Wall Street expectations, however. Dexcom reported adjusted earnings of 32 cents per share on revenue of $921 million in revenue. Those results surpassed the earnings of $1.10 per share and $2.2 billion in revenue anticipated by analysts polled by LSEG.

Persons: Dexcom, FactSet, Gilead, Skechers, L3Harris, Macheel, Darla Mercado Organizations: Microsoft, Intel, Gilead Sciences, LSEG Locations: LSEG .

Some companies that are about to report earnings could see a slide in their share prices. With the busiest week of earnings season underway, investors are certainly in for a hectic time. Nearly a third of the companies in the S & P 500 are scheduled to report their earnings this week. CNBC Pro screened the S & P 500 for companies that could see their stocks tumble after earnings. Industrial technology company Rockwell Automation has had its earnings revised downward 29 times in the past three months.

Persons: Myers Squibb, Steve Chesney Organizations: CNBC Pro, Myers, Bristol, Myers Squibb, Rockwell Automation, Gilead Sciences Locations: Bristol, Biopharmaceutical, Gilead

☆ The US dollar is strengthening. Here’s what’s driving the rally and what it means for Americans
▼ + stars: | 2024-04-21 | by ( Bryan Mena | ) edition.cnn.com time to read: +7 min

What does the dollar rally mean internationally? The US Commerce Department releases March figures on new orders for durable goods. The US Commerce Department releases its first estimate of first-quarter gross domestic product. The US Labor Department reports the number of new applications for unemployment benefits in the week ended April 20. The US Commerce Department releases March figures on household spending, income and the Fed’s preferred inflation gauge.

Persons: it’s, Michelle Bowman, Bell, Claudio Irigoyen, It’s, Samantha Delouya, ”, eMarketer, Ross Benes, Wall, Read, Lockheed Martin, Raymond James, Northrop Organizations: Washington CNN, Federal Reserve, Bank of America, Netflix, Verizon, Truist, Albertsons, The Chicago Fed, Visa, Tesla, Pepsico, Novartis, UPS, Lockheed, Banco Santander, Spotify, General Motors, Halliburton, Global, US Commerce Department, Meta, IBM, Boeing, Chipotle, Hilton, Ford, Hasbro, Whirlpool, Wyndham, Microsoft, Mobile, Caterpillar, Comcast, Intel, P Global, Honeywell, Gilead, Northrop Grumman, Valero, Capital, Nasdaq, Southwest Airlines, American Airlines, Citizens Financial, US Labor Department, National Association of Realtors, Bank of Japan, Exxon Mobil, Chevron, HCA Healthcare, Colgate, Palmolive, Phillips, Charter Communications, University of Michigan Locations: Europe, Japan, China, Roku

☆ Live Updates: World Leaders Urge Restraint as Israel Weighs Retaliation Against Iran
▼ + stars: | 2024-04-15 | by ( Mike Ives | ) www.nytimes.com time to read: +5 min

Israeli military analysts are divided on whether a more direct confrontation with Iran would alter the war in Gaza. But it occurred against the backdrop of the war in Gaza, where Israel is battling Hamas, a militant group funded and armed by Iran. Some analysts argued that the implications for Gaza would depend on whether Israel responded with a major counterattack against Iran. Other military experts, however, dismissed the link between the Iranian attack and the war in Gaza. General Gilead said that Israel’s army had enough resources to fight against Iran and continue to wage war against Hamas in Gaza.

Persons: Israel, Shlomo Brom, General Brom, “ It’s, Benjamin Netanyahu, “, ”, Amos Gilead, General Gilead, Giora Eiland, Eiland, Mr, Netanyahu, ” Aaron Boxerman Organizations: Hamas, Israel’s National Security Council Locations: Khan Yunis, Gaza, Iran, Israel, Israeli, Damascus, Rafah, United States, Britain, Jordan, Lebanon, Jerusalem

☆ No One Has Ever Read Genesis Like This
▼ + stars: | 2024-03-06 | by ( Francis Spufford | ) www.nytimes.com time to read: +2 min

READING GENESIS, by Marilynne RobinsonMarilynne Robinson’s “Reading Genesis” is a writer’s book, not a scholar’s; it has no footnotes. Its power lies in the particular reading it gives us of one of the world’s foundational texts, which is also one of the foundations of the Pulitzer Prize-winning author’s mind and faith. We want to know what Robinson thinks of Genesis for the same reason we’d want to know what Tolstoy thought of it. The spirit of God moves on the face of the waters, and eventually, far off in Idaho, the novelist’s bedsheets stir. But the surprising thing about “Reading Genesis,” given that it’s by a writer who can make even nonbelievers feel the presence of the thing they disbelieve, is that it is hardly interested in the numinous.

Persons: Marilynne Robinson, Robinson, Genesis, Tolstoy, Gilead, Jacob, sideshows, herdsmen, ” Locations: Idaho

☆ Opinion | Marilynne Robinson on Biblical Beauty, Human Evil and the Idea of Israel
▼ + stars: | 2024-03-05 | by ( The Ezra Klein Show | ) www.nytimes.com time to read: +1 min

Marilynne Robinson is one of the great living novelists. She has won a Pulitzer Prize and a National Humanities Medal, and Barack Obama took time out of his presidency to interview her at length. In recent years, Robinson has tightened the links between her literary pursuits and her Christianity, writing essays about Calvinism and other theological traditions. Her forthcoming work of nonfiction is “Reading Genesis,” a close reading of the first book of the Old Testament (or the Torah, as I grew up knowing it). No matter one’s faith, Robinson unearths wisdom in this core text that applies to many questions we wrestle with today.

Persons: Marilynne Robinson, Barack Obama, “, Ezra Klein, Robinson, ” Organizations: Humanities, Apple, Spotify, Amazon Music, Google Locations: “ Gilead, Idaho, Israel

☆ Kate DiCamillo Says ‘Paying Attention Is a Way to Love the World’
▼ + stars: | 2024-02-29 | by ( ) www.nytimes.com time to read: +2 min

I’m happy to report that the books are now organized alphabetically by author, and the extra copies have been put into other people’s hands. What’s the last great book you read? For me a great book is a book that I want to make someone else read immediately. And, too, a great book is one that makes me want to tell a story back. The last story that made me feel that way was in the 2023 “Best American Short Stories.” It’s by Da-Lin.

Persons: Alice McDermott’s “, McDermott, Niall Williams’s “, Nehisi Coates, Gene Luen Yang, Carlo Rovelli, ”, Lin Locations: Gilead

☆ These dividend stocks are poised for a rebound, according to BMO
▼ + stars: | 2024-02-21 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Dividend stocks have come under pressure in today's higher interest rate environment as investors have turned to bonds with juicy yields. They all have a next-twelve-months price-to-earnings ratio lower than the index and a dividend yield higher than the index. It has a 4.3% dividend yield and has gained about 1% year to date. Another utility play, Exelon , has a 4% dividend yield and is also up less than 1% so far this year. Lastly, investment banking giant Morgan Stanley has slipped nearly 9% so far this year and has a 4% dividend yield.

Persons: Brian Belski, Belski, Hunter C, Gary, Exelon, Gilead, Morgan Stanley, Ted Pick, — CNBC's Michael Bloom Organizations: BMO Capital Markets, American Electric, American Electric Power, Icahn Capital, Gilead Sciences, Therapeutics Locations: U.S

☆ Stocks making the biggest moves midday: New York Community Bancorp, Diamondback Energy, VF Corp. and more
▼ + stars: | 2024-02-12 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

Bank of America also reiterated its neutral rating on Monday, while noting that leadership has "the playbook to turn things around." Diamondback Energy — The shale producer jumped 9.4% after announcing its purchase of Endeavor Energy, the biggest private company that produces natural resources from the Permian Basin. CymaBay Therapeutics , Gilead — Shares of CymaBay soared 25.4% after Gilead agreed to buy the drug developer. The deal comes as Gilead, whose shares were up around 1% in Monday's session, looks to expand beyond HIV drugs. Marqeta — The credit card technology stock added 5.7% after a Bank of America upgrade to buy from neutral.

Persons: Gilead, Bracken Darrell, Trimble, —, Joe Ahlersmeyer, Piper Sandler, Teva, Samantha Subin, Sarah Min Organizations: New York Community Bancorp, Bank of America, Endeavor Energy, CymaBay Therapeutics, Gilead, VF Corp, Reuters, Mohawk Industries, Deutsche Bank, Citi, Space Development Agency, Teva Pharmaceutical —, JPMorgan, Nvidia Locations: Israel

☆ Brian Belski makes big trades on Snap, Chesapeake Energy, DoorDash, Gilead, and UnitedHealth
▼ + stars: | 2024-02-07 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBrian Belski makes big trades on Snap, Chesapeake Energy, DoorDash, Gilead, and UnitedHealthBrian Belski, chief investment strategist at BMO Capital Markets, joins 'Halftime Report' to break down his latest trades.

Persons: Brian Belski Organizations: Chesapeake Energy, BMO Capital Markets Locations: Gilead

☆ Stocks making the biggest moves after hours: Chipotle, Snap, Ford, Warner Bros. Discovery and more
▼ + stars: | 2024-02-06 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Mercury Systems — Shares of the technology company fell nearly 12% after missing Wall Street estimates in the fiscal second quarter. Viasat — Shares in the communications firm gained more than 5% after Viasat surpassed Wall Street estimates for revenue in the third quarter. The company notched revenue of $1.13 billion while analysts polled by FactSet forecast $1.11 billion. Analysts polled by LSEG expected the company to earn 77 cents per share on revenue of $3.24 billion. Chipotle — Shares added nearly 3% after beating Wall Street estimates on the top and bottom lines in the fourth quarter.

Persons: FactSet, LSEG, Chipotle Organizations: Mercury, Viasat —, Viasat, Wall, FactSet, LSEG, Corp, —, Gilead Sciences, Gilead Sciences — Stock, Ford — Stock, Ford, Disney, Warner Bros, Discovery, Fox Corp, Fox, Warner Bros ., ESPN Locations: Gilead, Gilead Sciences —

☆ 8 more of our stocks report earnings next week. Here's what we want to see
▼ + stars: | 2024-02-03 | by ( Zev Fima | ) www.cnbc.com time to read: +13 min

The three major averages posted gains for the fourth week in row, lifted by strong quarterly earnings results for most of the Big Tech companies and a strong jobs report. A weaker ADP Employment report on Wednesday provided no read-through to the monster January jobs report Friday. Here's what we're keeping an eye on in the coming week: 1. Earnings: It's another big earnings week head for the portfolio, with 8 more of our companies reporting. Consistency is what we appreciate most from nat gas giant Linde , so we're hoping for another quarter of solid earnings growth Tuesday.

Persons: Estee Lauder, Eli Lilly, Mounjaro, Nelson Peltz, Estée Lauder, Tyson, CARR, Jacobs, Willis Towers Watson, Edwards, Walt Disney, Oscar Health, Philip Morris, Armour, BAX, BILL, Jim Cramer's, Jim Cramer, Jim, George Frey Organizations: Big Tech, Dow Jones Industrial, Nasdaq, PMI, Apple, Starbucks, Procter, Gamble, GE Healthcare, DuPont, Linde, Ford, General Motors, Trian Partners, Disney, ESPN, Wynn Resorts, Wynn, Vegas, Prix, Estée Lauder Companies, Caterpillar, McDonalds Corp, Allegiant Travel, Bowlero Corp, Tyson Foods, TSN, Air Products & Chemicals, IDEXX Laboratories, CNA Financial Corp, CNA, Timken Company, Graham Corporation, Mesa Laboratories, Sphere Entertainment, Loews Corp, Technologies, Vertex Pharmaceuticals, Semiconductors, Simon Property Group, Amkor Technology, FMC Corporation, FMC, BellRing Brands, Crown Holdings, ChampionX Corporation, Golub Capital BDC, Flexsteel Industries, Kilroy Realty Corp, Gladstone Capital Corp, Unibanco, S.A, Snack Foods Corp, Kimball Electronics, Skyline Corp, Cabot Corporation, Simpson Manufacturing Co, Varonis Systems, Co, GE HealthCare, Linde plc, LIN, Spotify Technology S.A, BP, Hertz Global Holdings, AeroSystems Holdings, Toyota Motor Corp, Cummins, CMI, Software Technologies, AGCO Corporation, Carrier Global Corporation, Lear Corp, CONSOL Energy, Centene Corporation, Gartner, Arcbest Corp, CTS Corporation, Energizer Holdings, Hamilton Lane Incorporated, KKR, Precision Drilling Corporation, Frontier Group Holdings, Waters Corp, Alfa Laval, Aramark Holdings Corp, FirstService Corporation, Garden Sports Corp, New Jersey Resources Corp, nVent Electric plc, PJT Partners, Resources, Sensata Technologies, Ford Motor Company, Enphase Energy, Grill, VF Corp, Edwards Lifesciences Corp, Gilead Sciences, Lumen Technologies, Cognizant Technology Solutions Corp, Weatherford International plc, Amcor plc, Arrowhead Pharmaceuticals, Advanced Energy Industries, Uber Technologies, CVS Health, Roblox Corporation, Ares Capital Corp, Bunge, XPO Logistics, Scotts Miracle, Gro Company, Berry Global, Flex LNG, Equinor ASA, Griffon Corporation, OneMain Holdings, Brookfield Asset Management, Emerson Electric Co, Hilton Worldwide Holdings, Reynolds Consumer Products, Silicon Laboratories, Brands, Sciences, CDW Corp, Fox Corporation, WYNN, PayPal, Arm Holdings plc, ARM, Axcelis Technologies, Mattel, Paycom, Annaly Capital Management, McKesson Corp, Health Corporation, O'Reilly Automotive, Allstate Corp, Fluence Energy, Power Systems, Digital Turbine, Blue Bird Corp, Everest Group, Omega HealthCare, Coty, COTY, ConocoPhillips, Cameco Corp, Philip Morris International, Spirit Airlines, Hershey Company, Lightspeed Commerce, Aurora Cannabis, Lincoln National Corp, P, Tenet Healthcare Corp, Asbury Automotive Group, Arrow Electronics, Baxter International, PetMed, Boyd Gaming Corp, FirstEnergy Corp, Motorola Solutions, Terex Corp, PepsiCo, Growth, AMC Networks, Owl, American Pipeline, TELUS International, Magna International, Newell Brands, Jim Cramer's Charitable, CNBC, Bloomberg, Getty Locations: U.S, China, Macau, Wynn Macau, Valvoline, VVV, ALFVY, Madison, New Jersey, Gilead, Ceridian, ORLY, Paycor, Aurora, Provo , Utah

☆ Gilead stock falls after lung cancer study results disappoint
▼ + stars: | 2024-01-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

The results are a blow to Gilead, which is working to become a power player in the cancer space. Patients with advanced or metastatic non-small cell lung cancer who took Trodelvy lived longer than those who got chemotherapy alone, according to Gilead. The drugmaker said it will discuss the results with regulators and identify whether certain lung cancer patients may still benefit from the drug. Jefferies analyst Michael Yee said Gilead's trial results are not "totally surprising" to the firm because data from early studies was mixed and data for competing drugs was "lackluster." Yee added that the trial results could "dent" investor confidence about whether Gilead will have significant sales in oncology.

Persons: Trodelvy, Michael Yee, Yee, Gilead Organizations: Jefferies Locations: Gilead

☆ Three-Stock Lunch: Affirm Holdings, Gilead Sciences and 3M
▼ + stars: | 2024-01-22 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Affirm Holdings, Gilead Sciences and 3MGeorge Ball, chairman at Sanders Morris Harris, joins 'Power Lunch' to discuss Ball's investment take on three stocks: Affirm Holdings, Gilead Sciences, and 3M.

Persons: George Ball, Sanders Morris Harris Organizations: Gilead Sciences

Search resuls for: "gilead"

25 mentions found